Navigation Links
Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management
Date:11/9/2009

Product release is a research industry first, allowing veterinary research subjects, research facilities and research safety study data to be managed in one software application.

Cedar Knolls, NJ (PRWEB) November 9, 2009 -- Xybion Medical Systems announced today that it has unveiled Pristima™ VM, an integrated enterprise software solution for research facilities that track the use and care of veterinary research subjects. Pristima™ VM has been engineered to operate either stand alone or, more importantly, as an integrated solution with Xybion's core Pristima™ product that is in use in many of the world's premier pharmaceutical, contract research organization (CRO) and chemical research facilities that conduct product safety testing and research.

The integration of Pristima™ VM with the Pristima™ preclinical solution is a completely new way of thinking for vendors in this industry. This solution is filling a market void that the industry has been pressing vendors to address. Applications on the market today address only the animal management side of the business or the safety testing toxicology and pathology side of product research and development, leaving critical gaps in the flow of information for pharmaceutical, CRO or other research organizations. Xybion has now closed that gap and provided something that no other vendor has been able to, a conduit between the business, animal management and scientific aspects of research.

Pristima™ VM will be publicly debuted at the American Association for Laboratory Animal Science's National Meeting in Denver November 9-11, 2009 at Booth #506. To receive information about Pristima™ VM or Pristima™ visit http://www.xybion.com.

About Xybion Medical Systems
Xybion is the enterprise system partner of choice for life sciences product companies and research organizations worldwide. In addition to Pristima, Xybion provides professional services, consulting, training and validation activities to clients throughout the world. (http://xybion.com)

###

Read the full story at http://www.prweb.com/releases/2009/11/prweb3167884.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Korea Institute of Toxicology Implementing Xybion's Pristima™
2. Summerhill Biomass Systems Unveils Solid Biomass Technology System at Syracuse Expo
3. Healthnostics Unveils Biomedical Content Strategy for Medbioworld.com
4. Signatec Unveils PX14400, Its High-Speed PCI-Express Digitizer Capable of Sustained Recordings Over 1.2 GB/s with Xilinx Virtex-5 FPGAs for Embedded Real-Time Processing
5. Panther Expedited Services Unveils New Brand; Services Include Ground, Air, Ocean, & Logistics
6. ChemOutsourcing Unveils 2009 Attendee List for September Show in New Jersey
7. MedNet Solutions Unveils New Naming and Functionality for its Flagship EDC/eClinical Offering
8. Atherotech Unveils New Cardiometabolic Test Panels
9. DNA 11 Unveils Modern-Day Family Portraits at The Museum of Science and Industry's Smart Home: Green + WIRED Exhibit
10. Pharma ChemOutsourcing Unveils 100 Pharma & Biotech Speaker Faculty for 2009 Conference September 14-16 in Long Branch, NJ
11. Medicsight Unveils New Version of ColonCAD(TM) at ECR 2009
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Xybion Unveils Pristima™ VM, an Integrated Enterprise Software Solution for Vivarium and Veterinary Care Management
(Date:3/28/2017)... DIEGO , March 28, 2017  Viking Therapeutics, ... on the development of novel therapies for metabolic and ... Brian Lian , Ph.D., will deliver a corporate ... Annual NASH Investor Conference, being held April 3, 2017 ... Details for this presentation are as follows: ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... and diminished effectiveness over time. A recent study published in STEM CELLS suggests ... stimulating subventricular zone (SVZ) stem cells to produce more neural cells. , ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... the development of a new orally administered treatment for Alzheimer’s disease (AD), today ... John Didsbury states, “As we seek to uniquely treat the metabolic dysfunctions inherent ...
(Date:3/27/2017)... 27, 2017 Cousins Properties (NYSE: CUZ ... biotechnology companies, has signed a 10-year, approximately 125,000 square-foot lease ... asset located in the Westshore submarket of Tampa, ... Amgen has chosen Corporate Center for their new location in ... president and chief executive officer of Cousins Properties. "Amgen is ...
Breaking Biology Technology:
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. ... the Avamere Family of Companies (Avamere Health Services, Infinity ... a six-month research study that will apply the power ... at senior living and health centers. By analyzing data ... to gain insights into physical and environmental conditions, and ...
(Date:2/14/2017)... WINSTON-SALEM, N.C. , Feb. 14, 2017  Wake ... FRY-shlog), M.D., as its new chief executive officer (CEO). ... succeeds CEO John D. McConnell , M.D., who ... new position at the Medical Center, after leading it ... oversee the full scope of Wake Forest Baptist,s academic ...
(Date:2/10/2017)... Research and Markets has announced ... - Scientific and Commercial Aspects" to their offering. ... Biomarkers ... with therapy for selection of treatment as well for monitoring ... of disease in modern medicine. Biochip/microarray technologies and next generation ...
Breaking Biology News(10 mins):